2017
DOI: 10.1093/annonc/mdx665.018
|View full text |Cite
|
Sign up to set email alerts
|

Study of immunohistochemical expression of VEGF and its association with HPV E6 And E7 oncoproteins in oral and oropharyngeal squamous cell carcinoma

Abstract: were 74.0% and 47.7%(p ¼ 0.0199); the 5-year disease-specific survival rates,83.4% and 61.7% (p ¼ 0.1158); and the 5-year local control rates, 70.7% and 57.4% (p ¼ 0.1170) for the surgery and RT groups, respectively. Of the 81 cases, 43 (53.1%) were multiple primary cancers, of which 22 (27.2%) were in the head and neck region and all were metachronous. Conclusions: Initial surgery for stage I/II OPC is a useful therapeutic strategy considering the high incidence of multiple primary cancers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…51 However, the study of immunohistochemical expression of VEGF with regard to HPV status in oral and oropharyngeal cell carcinoma shows no significant difference in VEGF expression to HPV status. 52 Further analysis of VEGF expression with regard to HPV status needed to be performed using more robust detection method such as ELISA on OSCC samples to validate the VEGF expression in HPV-related OSCC.…”
Section: Vegf/vegfr and Hpv-related Osccmentioning
confidence: 99%
“…51 However, the study of immunohistochemical expression of VEGF with regard to HPV status in oral and oropharyngeal cell carcinoma shows no significant difference in VEGF expression to HPV status. 52 Further analysis of VEGF expression with regard to HPV status needed to be performed using more robust detection method such as ELISA on OSCC samples to validate the VEGF expression in HPV-related OSCC.…”
Section: Vegf/vegfr and Hpv-related Osccmentioning
confidence: 99%
“…Data show that the 5-year survival rate of OSCC is only 50 to 60%, and some patients have advanced disease and local metastasis at the time of diagnosis, which is not conducive to clinical treatment (4,5). A previous study stated that the patients with advanced oral cancer had a poor 3-year survival rate (6). At present, the most effective treatment for patients with locally advanced OSCC suitable for resection is comprehensive treatment based on radical surgery (7).…”
Section: Introductionmentioning
confidence: 99%